Samsara Bio Capital, LLC Syros Pharmaceuticals, Inc. Transaction History

Samsara Bio Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.78 - $8.9 $794,169 - $9.06 Million	-1,018,166 Reduced 53.6%	881,450 $5.68 Million
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $295,374 - $1.1 Million	-289,583 Reduced 13.23%	1,899,616 $2.26 Million
Q4 2020 Feb 17, 2021	BUY	$6.66 - $14.66 $5.2 Million - $11.5 Million	781,250 Added 55.49%	2,189,199 $23.8 Million
Q3 2020 Nov 16, 2020	SELL	$8.69 - $14.47 $1.42 Million - $2.37 Million	-163,954 Reduced 10.43%	1,407,949 $11.6 Million
Q2 2020 Aug 14, 2020	SELL	$5.21 - $11.03 $805,987 - $1.71 Million	-154,700 Reduced 8.96%	1,571,903 $15.9 Million
Q2 2019 Aug 14, 2019	BUY	$5.5 - $9.75 $3.67 Million - $6.5 Million	666,665 Added 62.9%	1,726,603 $15.2 Million
Q4 2018 Feb 14, 2019	BUY	$5.55 - $11.34 $5.88 Million - $12 Million	1,059,938 New	1,059,938 $5.9 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.